2006Journal of Modern Food and PharmaceuticalsRequires access

Study on bioequivalence of levofloxacin tablets in healthy volunteers

Xiao Li

Open publisher page 0 citations

Abstract

Objective To evaluate the relative bioavailability and bioequivalence of test levofloxacin tablets from different manufactures.Methods 18 male healthy volunteers orally took a single dose of 200 mg tablets in randamized self-crossover ways.The plasma concentration of levofloxacin was determined by RP-HPLC with fluorescent detector.Results The pharmacokinetic parameters of reference and test drugs were as follow : T_(max)(1.03±0.67) and(0.93±0.38)h;C_(max)(2363.29±552.13) and(2499.25±573.31) ng/ml;T_(1/2β)(5.57±0.92) and(6.04±0.55)h;MRT(7.77±1.14) and(8.02±0.68)h;AUC_((0→t))(13790.96±2171.28) and(13894.83±1873.47) ng·h·ml~(-1),respectively.The relative bioavailability of levofloxacin tablet was(99.40±9.70)%.There was no statistical difference between levofloxacin tablet in pharmacokinetic parameters(P0.05).Conclusion Two preparations of levofloxacin tablets are bioequivalence.

About this research paper

What this paper is about

Objective To evaluate the relative bioavailability and bioequivalence of test levofloxacin tablets from different manufactures.Methods 18 male healthy volunteers orally took a single dose of 200 mg tablets in randamized self-crossover ways.The plasma concentration of levofloxacin was determined by RP-HPLC with fluorescent detector.Results The pharmacokinetic parameters of reference and test drugs were as follow : T_(max)(1.03±0.67) and(0.93±0.38)h;C_(max)(2363.29±552.13) and(2499.25±573.31) ng/ml;T_(1/2β)(5.57±0.92) and(6.04±0.55)h;MRT(7.77±1.14) and(8.02±0.68)h;AUC_((0→t))(13790.96±2171.28) and(13894.83±1873.47) ng·h·ml~(-1),respectively.The relative bioavailability of levofloxacin tablet was(99.40±9.70)%.There was no statistical difference between levofloxacin tablet in pharmacokinetic parameters(P0.05).Conclusion Two preparations of levofloxacin tablets are bioequivalence.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To evaluate the relative bioavailability and bioequivalence of test levofloxacin tablets from different manufactures.Methods 18 male healthy volunteers orally took a single dose of 200 mg tablets in randamized self-crossover ways.The plasma concentration of levofloxacin was determined by RP-HPLC with fluorescent detector.Results The pharmacokinetic parameters of reference and test drugs were as follow : T_(max)(1.03±0.67) and(0.93±0.38)h;C_(max)(2363.29±552.13) and(2499.25±573.31) ng/ml;T_(1/2β)(5.57±0.92) and(6.04±0.55)h;MRT(7.77±1.14) and(8.02±0.68)h;AUC_((0→t))(13790.96±2171.28) and(13894.83±1873.47) ng·h·ml~(-1),respectively.The relative bioavailability of levofloxacin tablet was(99.40±9.70)%.There was no statistical difference between levofloxacin tablet in pharmacokinetic parameters(P0.05).Conclusion Two preparations of levofloxacin tablets are bioequivalence.

Key concepts: Bioequivalence, Levofloxacin, Bioavailability, Pharmacokinetics, Crossover study, Pharmacology, High-performance liquid chromatography, Medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Study on bioequivalence of levofloxacin tablets in healthy volunteers — Research Paper | ScholarLens